On
Also, on
Investor Contact:
617-430-7576
daniel@lifesciadvisors.com
Media Contact:
Sarah O’Connell
soconnell@vergescientific.com
![](https://ml.globenewswire.com/media/NzBiNTE2NTMtOGIxOS00NzdiLWEyMmYtMWUxNTc5YTUzMDQ5LTEwMTcxMTY=/tiny/Genocea-Biosciences-Inc-.png)
2022 GlobeNewswire, Inc., source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
On
Also, on
Investor Contact:
617-430-7576
daniel@lifesciadvisors.com
Media Contact:
Sarah O’Connell
soconnell@vergescientific.com
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-.--% | 58 | |
+16.59% | 44.87B | |
-10.62% | 37.8B | |
+40.49% | 37.61B | |
+29.92% | 31.32B | |
-9.78% | 27.4B | |
+12.34% | 26.32B | |
+41.53% | 14.07B | |
+31.49% | 12.5B | |
-7.40% | 11.23B |